CPIG
VRTX icon

Chicago Partners Investment Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Chicago Partners Investment Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Buy
2,455
+1,285
+110% +$569K 0.02% 583
2026
Q1 		$512K Buy
1,170
+303
+35% +$141K 0.01% 874
2025
Q4 		$406K Sell
867
-140
-14% -$60.3K 0.01% 882
2025
Q3 		$425K Sell
1,007
-117
-10% -$48.9K 0.01% 785
2025
Q2 		$536K Buy
1,124
+176
+19% +$81.1K 0.02% 570
2025
Q1 		$412K Buy
948
+141
+17% +$65.7K 0.01% 582
2024
Q4 		$333K Buy
807
+332
+70% +$154K 0.01% 623
2024
Q3 		$223K Buy
475
+29
+7% +$13.9K 0.01% 717
2024
Q2 		$224K Buy
+446
New +$194K 0.01% 690
2018
Q4 		– Sell
-32
Closed -$5K – 909
2018
Q3 		$5K Buy
+32
New +$5.7K ﹤0.01% 926

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Chicago Partners Investment Group's VRTX Position: Q2 2026 in Review

Chicago Partners Investment Group increased its Vertex Pharmaceuticals (VRTX) stake by 110% in Q2 2026, buying an estimated $569K and bringing the position to 2,455 shares worth $1.16M. The position accounts for 0.02% of the portfolio, ranked #583.

Chicago Partners Investment Group first reported a position in VRTX in Q3 2018 and has held it in 10 quarters since. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Chicago Partners Investment Group held 2,455 shares of Vertex Pharmaceuticals worth $1.16M as of Q2 2026.
  • Chicago Partners Investment Group bought 1,285 Vertex Pharmaceuticals shares in Q2 2026, an estimated $569K.
  • Vertex Pharmaceuticals made up 0.02% of Chicago Partners Investment Group's portfolio in Q2 2026, its #583 holding.
  • Chicago Partners Investment Group first reported a position in Vertex Pharmaceuticals in Q3 2018 and has held it in 10 quarters since.
  • 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.